Dissemin is shutting down on January 1st, 2025

Published in

Lippincott, Williams & Wilkins, Epidemiology, 1(28), p. 127-135, 2017

DOI: 10.1097/ede.0000000000000574

Links

Tools

Export citation

Search in Google Scholar

Spatial prediction of Coxiella burnetii outbreak exposure via notified case counts in a dose-response model

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

We develop a novel approach to study an outbreak of Q fever in 2009 in the Netherlands by combining a human dose-response model with geostatistics prediction to relate probability of infection and associated probability of illness to an effective dose of Coxiella burnetii. The spatial distribution of the 220 notified cases in the at-risk population are translated into a smooth spatial field of dose. Based on these symptomatic cases, the dose-response model predicts a median of 611 asymptomatic infections (95% range 410 to 1,084) for the 220 reported symptomatic cases in the at-risk population; 2.78 (95% range 1.86 to 4.93) asymptomatic infections for each reported case. The low attack rates observed during the outbreak range from 3.4×10 to 2.0×10. The estimated peak levels of exposure extend to the north-east from the point source with an increasing proportion of asymptomatic infections further from the source. Our work combines established methodology from model-based geostatistics and dose-response modeling allowing for a novel approach to study outbreaks. Unobserved infections and the spatially varying effective dose can be predicted using the flexible framework without assuming any underlying spatial structure of the outbreak process. Such predictions are important for targeting interventions during an outbreak, estimating future disease burden, and determining acceptable risk levels.